Search

Search Constraints

You searched for: Author/Creator Harrow, S.

Search Results

22. PO-0752: Isotoxic Intensity Modulated Radiotherapy in stage III NSCLC – A feasibility study. (April 2018)

24. Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic. Issue 8 (August 2020)

27. Toxicity and Efficacy of Stereotactic Ablative Body Radiotherapy for Moderately Central Non-small Cell Lung Cancers Using 50 Gy in Five Fractions. Issue 4 (April 2020)

28. UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. Issue 5 (May 2022)

29. UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy. Issue 1 (January 2018)